Diabetic Ketoacidosis Management - THD Internal Medicine :糖尿病酮症酸中毒的管理- THD内科

上传人:笛音 文档编号:47598929 上传时间:2018-07-03 格式:PPT 页数:29 大小:539KB
返回 下载 相关 举报
Diabetic Ketoacidosis Management - THD Internal Medicine :糖尿病酮症酸中毒的管理- THD内科_第1页
第1页 / 共29页
Diabetic Ketoacidosis Management - THD Internal Medicine :糖尿病酮症酸中毒的管理- THD内科_第2页
第2页 / 共29页
Diabetic Ketoacidosis Management - THD Internal Medicine :糖尿病酮症酸中毒的管理- THD内科_第3页
第3页 / 共29页
Diabetic Ketoacidosis Management - THD Internal Medicine :糖尿病酮症酸中毒的管理- THD内科_第4页
第4页 / 共29页
Diabetic Ketoacidosis Management - THD Internal Medicine :糖尿病酮症酸中毒的管理- THD内科_第5页
第5页 / 共29页
点击查看更多>>
资源描述

《Diabetic Ketoacidosis Management - THD Internal Medicine :糖尿病酮症酸中毒的管理- THD内科》由会员分享,可在线阅读,更多相关《Diabetic Ketoacidosis Management - THD Internal Medicine :糖尿病酮症酸中毒的管理- THD内科(29页珍藏版)》请在金锄头文库上搜索。

1、Diabetic Ketoacidosis ManagementHeidi Chamberlain Shea, MDEndocrine Associates of DallasGoals of Discussion Pathophysiology of DKA Biochemical criteria for DKA Treatment of DKA Prevention of DKA Hyperosmolar Nonketoic SyndromeEpidemiology Annual incidence in U.S. 5-8 per 1000 diabetic subjects 2.8%

2、of all diabetic admissions are due to DKA Overall mortality rate ranges from 2-10% Higher is older patientsDKA Precipitating Factors Failure to take insulin Failure to increase insulin Illness/Infection Pneumonia MI Stroke Acute stress Trauma Emotional Medical Stress Counterregulatory hormones Oppos

3、e insulin Stimulate glucagon release Hypovolmemia Increases glucagon and catecholamines Decreased renal blood flow Decreases glucagon degradation by the kidneyDiabetic KetoacidosisDue to: Severe insulin deficiency Excess counterregulatory hormones Glucagon Epinephrine Cortisol Growth hormoneRole of

4、Insulin Required for transport of glucose into Muscle Adipose Liver Inhibits lipolysis Absence of insulin Glucose accumulates in the blood Liver Uses amino acids for gluconeogenesis Converts fatty acids into ketone bodies Acetone, Acetoacetate, -hydroxybutyrate Increased counterregulatory hormonesCo

5、unterregulatory Hormones - DKAIncreases insulin resistanceActivates glycogenolysis and gluconeogenesisActivates lipolysisInhibits insulin secretionEpinephrineXXXXGlucagonXCortisolXXGrowth HormoneXXXInsulin DeficiencyGlucose uptake ProteolysisLipolysisAmino AcidsGlycerolFree Fatty AcidsGluconeogenesi

6、s GlycogenolysisHyperglycemiaHyperglycemiaKetogenesisAcidosisAcidosisOsmotic diuresisDehydrationDehydrationSigns and Symptoms of DKA Polyuria, polydipsia Enuresis Dehydration Tachycardia Orthostasis Abdominal pain Nausea Vomiting Fruity breath Acetone Kussmaul breathing Mental status changes Combati

7、ve Drunk ComaLab Findings Hyperglycemia Anion gap acidosis (Na + K) (Cl + Bicarb) 12 Bicarbonate 50020.00Complications of DKA Infection Precipitates DKA Fever Leukocytosis can be secondary to acidosis Shock If not improving with fluids r/o MI Vascular thrombosis Severe dehydration Cerebral vessels O

8、ccurs hours to days after DKA Pulmonary Edema Result of aggressive fluid resuscitation Cerebral Edema First 24 hours Mental status changes Tx: Mannitol May require intubation with hyperventilationOnce DKA Resolved Treatment Most patients require 0.5-0.6 units/kg/day Pubertal or highly insulin resist

9、ant patients 0.8-1.0 units/kg/day Long acting insulin 1/2-2/3 daily requirement NPH, Lente, Ultralente or Lantus Short acting insulin 1/3-1/2 given at meals Regular, Humalog, Novolog Give insulin at least 2 hours prior to weaning insulin infusion.Prevention of DKA Sick Day Rules Never omit insulin C

10、ut long acting in half Prevent dehydration and hypoglycemia Monitor blood sugars frequently Monitor for ketosis Provide supplemental fast acting insulin Treat underlying triggers Maintain contact with medical teamGoals of Discussion Pathophysiology of DKA Biochemical criteria for DKA Treatment of DK

11、A Prevention of DKA Hyperosmolar Nonketoic SyndromeHyperosmolar Nonketotic Syndrome Extreme hyperglycemia and dehydration Unable to excrete glucose as quickly as it enters the extracellular space Maximum hepatic glucose output results in a plateau of plasma glucose no higher than 300 -500 mg/dl When

12、 sum of glucose excretion plus metabolism is less than the rate which glucose enters extracellular space.Hyperosmolar Nonketotic Syndrome Extreme hyperglycemia and hyperosmolarity High mortality (12-46%) At risk Older patients with intercurrent illness Impaired ability to ingest fluids Urine volume

13、falls Decreased glucose excretion Elevated glucose causes CNS dysfunction and fluid intake impaired No ketones Some insulin may be present Extreme hyperglycemia inhibits lipolysisHyperosmolar Nonketotic Syndrome Presentation Extreme dehydration Supine or orthostatic hypotension Confusion coma Neurol

14、ogical findings Seizures Transient hemiparesis Hyperreflexia Generalized areflexia Hyperosmolar Nonketotic Syndrome Presentation Glucose 600 mg/dl Sodium Normal, elevated or low Potassium Normal or elevated Bicarbonate 15 mEq/L Osmolality 320 mOsm/LHyperosmolar Nonketotic Syndrome Treatment Fluid re

15、pletion NS 2-3 liters rapidly Total deficit = 10 liters Replete in first 6 hours Insulin Make sure perfusion is adequate Insulin drip 0.1U/kg/hr Treat underlying precipitating illnessClinical Errors Fluid shift and shock Giving insulin without sufficient fluids Using hypertonic glucose solutions Hyperkalemia Premature potassium administration before insulin has begun to act Hypokalemia Failure to administer potassium once levels falling Recurrent ketoacidosis

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 商业/管理/HR > 其它文档

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号